| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
254,036,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$22.93 - $22.93 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Herendeen Paul |
Exec. V.P. and CFO |
• • – |
2013-09-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(37,720) |
94,900 |
|
- |
|
| Osullivan Patrick J |
Director |
– • – |
2013-09-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,170) |
0 |
|
- |
|
| King John A |
Director |
– • – |
2013-09-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,170) |
0 |
|
- |
|
| Rodriguez Rama Francisco |
Senior V.P., Tech. Operations |
• – – |
2013-09-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,550) |
22,109 |
|
- |
|
| Sullivan Ryan T |
VP, General Counsel & Secr. |
• – – |
2013-09-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,420) |
18,040 |
|
- |
|
| Vincze Leslie Stephan |
SVP, Chief Compliance Officer |
• – – |
2013-09-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(32,980) |
0 |
|
- |
|
| Vincze Leslie Stephan |
SVP, Chief Compliance Officer |
• – – |
2013-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
32,980 |
32,980 |
|
- |
|
| Rodriguez Rama Francisco |
Senior V.P., Tech. Operations |
• – – |
2013-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,130 |
35,659 |
|
- |
|
| Halstead Michael |
Senior V.P., Corp. Development |
• – – |
2013-07-01 |
4 |
S |
$19.88 |
$7,276 |
D/D |
(366) |
51,840 |
|
- |
|
| Sullivan Ryan T |
VP, General Counsel & Secr. |
• – – |
2013-07-01 |
4 |
S |
$19.88 |
$3,360 |
D/D |
(169) |
26,460 |
|
- |
|
| Sullivan Ryan T |
VP, General Counsel & Secr.Off |
• – – |
2013-05-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
26,629 |
|
- |
|
| Osullivan Patrick J |
Director |
– • – |
2013-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,170 |
4,170 |
|
- |
|
| Bloem James H |
Director |
– • – |
2013-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,170 |
28,346 |
|
- |
|
| Howson Tamar D |
Director |
– • – |
2013-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,170 |
4,170 |
|
- |
|
| King John A |
Director |
– • – |
2013-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,170 |
4,170 |
|
- |
|
| Van Zoonen Marinus Johannes |
President, Europe/Intl & Mkt. |
• – – |
2013-04-01 |
4 |
S |
$13.41 |
$9,428 |
D/D |
(703) |
144,838 |
|
- |
|
| Connaughton John |
Director |
– • – |
2013-03-04 |
4 |
S |
$13.47 |
$142,655,490 |
I/I |
(10,590,608) |
0 |
|
- |
|
| Connaughton John |
Director |
– • – |
2013-03-04 |
4 |
D |
$0.00 |
$0 |
I/I |
(901,014) |
10,590,608 |
|
- |
|
| Ellman Herman |
Senior V.P., Clinical Devel. |
• – – |
2013-03-01 |
4 |
S |
$13.38 |
$22,293 |
D/D |
(1,666) |
181,223 |
|
- |
|
| Boissonneault Roger M |
CEO & President |
• • – |
2013-02-28 |
4 |
S |
$13.46 |
$252,175 |
D/D |
(18,730) |
2,312,618 |
|
- |
|
| Gilligan Claire A |
Senior V.P., Quality |
• – – |
2013-02-28 |
4 |
S |
$13.46 |
$31,694 |
D/D |
(2,354) |
77,632 |
|
- |
|
| Herendeen Paul |
Exec. V.P. and CFO |
• – – |
2013-02-28 |
4 |
S |
$13.46 |
$62,929 |
D/D |
(4,674) |
132,620 |
|
- |
|
| Halstead Michael |
Senior V.P., Corp. Development |
• – – |
2013-02-28 |
4 |
S |
$13.46 |
$23,521 |
D/D |
(1,747) |
52,206 |
|
- |
|
| Rodriguez Rama Francisco |
Senior V.P., Tech. Operations |
• – – |
2013-02-28 |
4 |
S |
$13.46 |
$11,040 |
D/D |
(820) |
30,529 |
|
- |
|
| Fuhrmann Rochelle |
Senior V.P., Finance |
• – – |
2013-02-28 |
4 |
S |
$13.46 |
$23,265 |
D/D |
(1,728) |
56,546 |
|
- |
|
380 Records found
|
|
Page 2 of 16 |
|
|
